Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients

Mycoses

Volumn 60, Issue 6, 2017, Pages 366-374

  Suhr, Mallory J ^a   Gomes Neto, João Carlos ^a   Banjara, Nabaraj ^a   Florescu, Diana F ^b   Mercer, David F ^b   Iwen, Peter C ^c   Hallen Adams, Heather E ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

candidaemia; fungaemia; microbiota; mycobiota

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; FUNGAL DNA; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; ECHINOCANDIN; LIPOPEPTIDE; TRIAZOLE DERIVATIVE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ANTIFUNGAL THERAPY; ARTICLE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDEMIA; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; ILEOSTOMY; ILEUM; INTESTINE FLORA; INTESTINE TRANSPLANTATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SHORT BOWEL SYNDROME; WICKERHAMOMYCES ANOMALUS; ADOLESCENT; ADULT; BLOOD; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; SMALL INTESTINE; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; HUMANS; INTESTINE, SMALL; ITRACONAZOLE; LIPOPEPTIDES; MALE; MULTILOCUS SEQUENCE TYPING; SEQUENCE ANALYSIS, DNA; TRANSPLANT RECIPIENTS; TRIAZOLES; YOUNG ADULT;

EID: 85011665660     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12603     Document Type: Article

References (48)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317.
2. Magill SS, Edwards JR, Bamberg W et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198–1208.
3. Moran G, Coleman D, Sullivan D. An introduction to the medically important Candida species. In: Calderon RA, Clancy CJ, eds. Candida and Candidiasis, 2nd edn. Washington, DC: ASM Press; 2012:11–25.
4. Gudlaugsson O, Gillespie S, Lee K et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172–1177.
5. Florescu DF, Qiu F, Mercer DF, Langnas AN, Shaf LR. Risk factors for systemic Candida infections in pediatric small bowel transplant recipients. Pediatr Infect Dis J. 2012;31:120–123.
6. Shoham S, Marr KA. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012;7:639–655.
7. Pirenne J, Kawai M. Intestinal transplantation: evolution in immunosuppression protocols. Curr Opin Organ Transplant. 2009;14:250–255.
8. Florescu DF, Qiu F, Langnas AN et al. Bloodstream infections during the first year after pediatric small bowel transplantation. Pediatr Infect Dis J. 2012;31:700–704.
9. Florescu DF, Islam KM, Grant W et al. Incidence and outcome of fungal infections in pediatric small bowel transplant recipients. Transpl Infect Dis. 2010;12:497–504.
10. Grossi PA. Clinical aspects of invasive candidiasis in solid organ transplant recipients. Drugs. 2009;69(Suppl 1):15–20.
11. Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011;11:1123–1130.
12. Huang YC, Lin TY, Leu HS, Wu JL, Chang HY. Yeast carriage on hands of hospital personnel working in intensive care units. J Hosp Infect. 1998;39:47–51.
13. Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implication and genotyping analysis. Infection. 1999;27:97–102.
14. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001;33:1959–1967.
15. Levin AS, Costa SF, Muss NS et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis. 1998;30:243–249.
16. Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis. 2000;31:545–553.
17. Sobel JD. The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. Curr Infect Dis Rep. 2006;8:427–433.
18. Harju S, Fedosyuk H, Peterson KR. Rapid isolation of yeast genomic DNA: Bust n' Grab. BMC Biotechnol. 2004;4:8.
19. Suhr MJ, Banjara N, Hallen-Adams HE. Sequence-based methods for detecting and evaluating the human gut mycobiome. Lett Appl Microbiol. 2016;62:209–215.
20. Oh PL, Martínez I, Sun Y, Walter J, Peterson DA, Mercer DF. Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants. Am J Transplant. 2012;12:753–762.
21. Kõljalg U, Nilsson RH, Abarenkov K et al. Towards a unified paradigm for sequence-based identification of fungi. Mol Ecol. 2013;22:5271–5277.
22. Bougnoux ME, Tavanti A, Bouchier C et al. Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol. 2003;41:5265–5266.
23. Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol. 2003;41:5709–5717.
24. Binelli CA, Moretti ML, Assis RS et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect. 2006;12:538–543.
25. Bautista-Muñoz C, Bolda XM, Villa-Tanaca L, Hernández-Rodríguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol. 2003;41:414–420.
26. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, 3rd Edn. CLSI document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
27. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement. CLSI document M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
28. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Third Informational Supplement. CLSI document M27-S3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
29. Arendrup MC, Cuenca-Estrella M, Lass-Florl C, Hope WW. Breakpoints for antifungal agents: an update from EUCAST focusing on echinocandins against Candida spp. and triazoles against Aspergillus spp. Drug Resist Updat. 2013;16:81–95.
30. Hallen-Adams HE, Kachman SD, Kim J, Legge RM, Martínez I. Fungi inhabiting the healthy human gastrointestinal tract: a diverse and dynamic community. Fungal Ecol. 2015;15:9–17.
31. Suhr MJ, Hallen-Adams HE. The human gut mycobiome: pitfalls and potentials – a mycologist's perspective. Mycologia. 2015;107:1057–1073.
32. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45:321–346.
33. Pasqualottoa AC, Sukiennika TCT, Severoa LC, de Amorima CS, Colombo AL. An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. Infect Control Hosp Epidemiol. 2005;26:553–558.
34. Aragão PA, Oshiro IC, Manrique EI et al. Pichia anomala outbreak in a nursery: exogenous source? Pediatr Infect Dis J. 2001;20:843–848.
35. Klempp-Selb B, Rimek D, Kappe R. Karyotyping of Candida albicans and Candida glabrata from patients with Candida sepsis. Mycoses. 2000;43:159–163.
36. Miranda LN, van der Heijden IM, Costa SF et al. Candida colonization as a source for candidaemia. J Hosp Infect. 2009;72:9–16.
37. Charles PE, Dalle F, Aube H et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31:393–400.
38. Magill SS, Swoboda SM, Johnson EA et al. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis. 2006;55:293–301.
39. Odds FC, Davidson AD, Jacobsen MD et al. Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol. 2006;44:3647–3658.
40. van Asbeck EC, Huang YC, Markham AN, Clemons KV, Stevens DA. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia. 2007;164:287–293.
41. Clark TA, Slavinski SA, Morgan J et al. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol. 2004;42:4468–4472.
42. Asmundscdóttir LR, Erlendsdóttir H, Haraldsson G, Guo H, Xu J, Gottfredsson M. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis. 2008;47:e17–e24.
43. Viviani MA, Cogliati M, Esposto MC, Prigitano A, Tortorano AM. Four-year persistence of a single Candida albicans genotype causing bloodstream infections in a surgical ward proven by multilocus sequence typing. J Clin Microbiol. 2006;44:218–221.
44. Robles JC, Koreen L, Park S, Perlin DS. Multilocus sequence typing is a reliable alternative method to DNA fingerprinting for discriminating among strains of Candida albicans. J Clin Microbiol. 2004;42:2480–2488.
45. Sabino R, Sampaio P, Rosado L, Stevens DA, Clemons KV, Pais C. New polymorphic microsatellite markers able to distinguish among Candida parapsilosis sensu stricto isolates. J Clin Microbiol. 2010;48:1677–1682.
46. Ostrosky-Zeichner L, Rex JH, Pappas PG et al. Antifungal susceptibility survey of 2,000 blood stream Candida isolates in the United States. Antimicrob Agents Chemother. 2003;47:3149–3154.
47. Prazynska M, Gospodarik E. In vitro effect of amphotericin B on Candida albicans, Candida glabrata, and Candida parapsilosis biofilm formation. Mycopathologia. 2014;177:19–27.
48. Battaglia M, Ditonnoa P, Selvaggioa O et al. Kidney transplants from infected donors: our experience. Transplant Proc. 2004;36:491–492.